趋势和晚期结果在老年患者接受中枢干预在美国的老年患者
Harun Kundi1, David J Cohen1, Martin B Leon2
1Cardiovascular Research Foundation, New York, New York, USA.
JACC. Cardiovascular interventions
|September 24, 2025
概括
过导管 mitra 干预在老年患者中正在上升,但5年死亡率仍然很高,受脆弱性和社会脆弱性的影响. 这些趋势凸显了在严重的甲骨管吐时需要个性化治疗策略的需要.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 严重的腹需要干预,以改善选择患者的治疗结果.
- 关于美肌干预趋势和长期结果的现实数据有限.
- 了解时间使用模式和死亡率因素对于老年人群至关重要.
研究的目的:
- 分析老年患者中中枢干预使用趋势.
- 为了确定5年死亡率的预测因子,米特拉干预后.
- 在现实环境中比较不同干预策略的结果.
主要方法:
- 使用的医疗保险和医疗补助服务中心索赔数据 (2017-2022年).
- 包括65岁以上的患者,接受手术或通过导管进行关干预.
- 主要终点是5年全因死亡率.
主要成果:
- 总体中膜干预增加了9.2%,手术减少,但跨导管端到端修复 (M-TEER) 和跨导管中膜置换 (TMVR) 的显着增长.
- 手术的五年死亡率为39.5%,TMVR为55.1%,M-TEER为61.9%,因脆弱性风险而有显著差异.
- 更高的社会脆弱性逐渐与死亡率的增加有关.
结论:
- 在老年患者中,越来越多地采用过导管 mitra 干预措施.
- 根据干预类型,脆弱性和社会脆弱性,五年死亡率存在显著差异.
- 脆弱性和社会经济因素是中枢干预后长期生存的关键决定因素.
相关概念视频
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Mitral Valve Prolapse II: Assessment and Management
425
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
425
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Mitral Stenosis II: Clinical features and Diagnostic Tests
220
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
220
Mitral Valve Prolapse III: Nursing Management
291
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
291
Mitral Stenosis IV: Nursing Management
247
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
247


